Achidi, E.A.Agbenyega, T.Allen, S.Amodu, O.Bojang, K.Conway, D.Corran, P.Deloukas, P.Djimde, A.Dolo, A.Doumbo, O.Drakeley, C.Duffy, P.Dunstan, S.Evans, J.Farrar, J.Fernando, D.Tran, T.H.Horstmann, R.Ibrahim, M.Karunaweera, N.Kokwaro, G.Koram, K.Kwiatkowski, D.Lemnge, M.Makani, J.Marsh, K.Michon, P.Modiano, D.Molyneux, M.E.Mueller, I.Mutabingwa, T.Parker, M.Peshu, N.Plowe, C.Puijalon, O.Ragoussis, J.Reeder, J.Reyburn, H.Riley, E.Rogers, J.Wilson, M.Ghansah, A.2012-05-022017-10-162012-05-022017-10-162008http://197.255.68.203/handle/123456789/907Large-scale studies of genomic variation could assist efforts to eliminate malaria. But there are scientific, ethical and practical challenges to carrying out such studies in developing countries, where the burden of disease is greatest. The Malaria Genomic Epidemiology Network (MalariaGEN) is now working to overcome these obstacles, using a consortial approach that brings together researchers from 21 countries.enArticle